
KraneShares MSCI All China Health Care Index ETF (KURE) Price & Chart
KURE ETF Chart & Stats
- Day’s Range
- $17.50 - $17.69
- 52-Week Range
- $14.38 - $19.93
- Previous Close
- $17.80
- Volume
- 21.42K
- Average Volume (3M)
- 75.66K
- AUM
- 108.52M
- NAV
- 17.69
- Expense Ratio
- 0.65%
- Holdings Count
- 43
- Beta
- 0.61
- Inception Date
- Feb 01, 2018
- Last Dividend Ex-Date
- Dec 22, 2025
- Dividend Yield
- (4.06%)
- Shares Outstanding
- 6,148,581
- Standard Deviation
- N/A
ETF Overview
KraneShares MSCI All China Health Care Index ETF
The KraneShares MSCI All China Health Care Index ETF (KURE) offers investors a unique opportunity to gain exposure to China's burgeoning healthcare sector, a pivotal component of the country's economic growth and innovation agenda. As a sector-focused ETF, KURE is designed to capture the dynamic and rapidly evolving landscape of Chinese healthcare, encompassing pharmaceuticals, biotechnology, medical devices, and healthcare services. Positioned within the broad-based niche of the healthcare sector, KURE provides targeted access to companies poised to benefit from China's increasing healthcare expenditure, aging population, and government initiatives aimed at enhancing healthcare quality and accessibility. The fund tracks the MSCI China All Shares Health Care 10/40 Index, ensuring a diversified portfolio that reflects the full spectrum of China's healthcare industry. Investors in KURE can expect exposure to both established giants and innovative newcomers, offering a balanced approach to capitalizing on the sector's growth potential. With its focus on a critical sector in one of the world's largest and fastest-growing economies, KURE stands out as an essential tool for those looking to diversify their portfolios with a strategic emphasis on China's healthcare advancements.
KraneShares MSCI All China Health Care Index ETF (KURE) Fund Flow Chart
KURE ETF FAQ
What was KURE’s price range in the past 12 months?
What is the AUM of KURE?
Does KURE pay dividends?
How many shares outstanding does KURE have?
Top 10 Holdings
| Name | Weight % |
|---|---|
| 6160BeOne Medicines Ltd | 8.81% |
| 1801Innovent Biologics | 7.96% |
| 2269Wuxi Biologics (Cayman) | 7.49% |
| 9926Akeso, Inc. | 4.16% |
| 1177Sino Biopharmaceutical | 3.58% |
| 1093CSPC Pharmaceutical Group | 3.39% |
| 2359WuXi AppTec Co., Ltd. Class H | 3.24% |
| 1548Genscript Biotech Corporation | 3.09% |
| 3692Hansoh Pharmaceutical Group Company Limited | 3.02% |
| 6990Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H | 2.06% |
| Total | 46.82% |

